Literature DB >> 20385962

Role of inotropic agents in the treatment of heart failure.

Joshua I Goldhaber1, Michele A Hamilton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20385962      PMCID： PMC2861129          DOI： 10.1161/CIRCULATIONAHA.109.899294

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  37 in total

1.  Sodium-calcium exchange: the phantom menace.

Authors:  J I Goldhaber
Journal:  Circ Res       Date:  1999-11-26       Impact factor: 17.367

Review 2.  beta-adrenergic receptor blockade in chronic heart failure.

Authors:  M R Bristow
Journal:  Circulation       Date:  2000-02-08       Impact factor: 29.690

Review 3.  Cardiac intracellular calcium release channels: role in heart failure.

Authors:  A R Marks
Journal:  Circ Res       Date:  2000-07-07       Impact factor: 17.367

Review 4.  Inotropic therapy for heart failure: an evidence-based approach.

Authors:  G M Felker; C M O'Connor
Journal:  Am Heart J       Date:  2001-09       Impact factor: 4.749

5.  Dyssynchronous Ca(2+) sparks in myocytes from infarcted hearts.

Authors:  S E Litwin; D Zhang; J H Bridge
Journal:  Circ Res       Date:  2000-11-24       Impact factor: 17.367

6.  Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure.

Authors:  Eiran Z Gorodeski; Eric C Chu; Jennifer R Reese; Mehdi H Shishehbor; Eileen Hsich; Randall C Starling
Journal:  Circ Heart Fail       Date:  2009-05-14       Impact factor: 8.790

7.  Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact.

Authors:  M H Yamani; S A Haji; R C Starling; L Kelly; N Albert; D L Knack; J B Young
Journal:  Am Heart J       Date:  2001-12       Impact factor: 4.749

8.  Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial.

Authors:  Michael S Cuffe; Robert M Califf; Kirkwood F Adams; Raymond Benza; Robert Bourge; Wilson S Colucci; Barry M Massie; Christopher M O'Connor; Ileana Pina; Rebecca Quigg; Marc A Silver; Mihai Gheorghiade
Journal:  JAMA       Date:  2002-03-27       Impact factor: 56.272

9.  The Na+-Ca2+ exchanger is essential for the action of cardiac glycosides.

Authors:  Hannes Reuter; Scott A Henderson; Tieyan Han; Robert S Ross; Joshua I Goldhaber; Kenneth D Philipson
Journal:  Circ Res       Date:  2002-02-22       Impact factor: 17.367

10.  Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.

Authors:  F Follath; J G F Cleland; H Just; J G Y Papp; H Scholz; K Peuhkurinen; V P Harjola; V Mitrovic; M Abdalla; E-P Sandell; L Lehtonen
Journal:  Lancet       Date:  2002-07-20       Impact factor: 79.321
View more
  20 in total

Review 1.  Cardiac arrest: resuscitation and reperfusion.

Authors:  Kaustubha D Patil; Henry R Halperin; Lance B Becker
Journal:  Circ Res       Date:  2015-06-05       Impact factor: 17.367

Review 2.  Novel therapeutic targets for the treatment of heart failure.

Authors:  Juan Tamargo; José López-Sendón
Journal:  Nat Rev Drug Discov       Date:  2011-06-24       Impact factor: 84.694

3.  Hemodynamic responses to small muscle mass exercise in heart failure patients with reduced ejection fraction.

Authors:  Zachary Barrett-O'Keefe; Joshua F Lee; Amanda Berbert; Melissa A H Witman; Jose Nativi-Nicolau; Josef Stehlik; Russell S Richardson; D Walter Wray
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-09-26       Impact factor: 4.733

Review 4.  Na/Ca exchange in the atrium: Role in sinoatrial node pacemaking and excitation-contraction coupling.

Authors:  Xin Yue; Adina Hazan; Sabine Lotteau; Rui Zhang; Angelo G Torrente; Kenneth D Philipson; Michela Ottolia; Joshua I Goldhaber
Journal:  Cell Calcium       Date:  2020-01-30       Impact factor: 6.817

5.  Palliative Care for Advanced Heart Failure in a Department of Veterans Affairs Regional Hospice Program: Patient Selection, a Treatment Protocol, and Clinical Course.

Authors:  George J Taylor; Dorothy M Lee; Catalin F Baicu; Michael R Zile
Journal:  J Palliat Med       Date:  2017-05-22       Impact factor: 2.947

Review 6.  Playing with cardiac "redox switches": the "HNO way" to modulate cardiac function.

Authors:  Carlo G Tocchetti; Brian A Stanley; Christopher I Murray; Vidhya Sivakumaran; Sonia Donzelli; Daniele Mancardi; Pasquale Pagliaro; Wei Dong Gao; Jennifer van Eyk; David A Kass; David A Wink; Nazareno Paolocci
Journal:  Antioxid Redox Signal       Date:  2011-03-03       Impact factor: 8.401

7.  Myocardial-restricted ablation of the GTPase RAD results in a pro-adaptive heart response in mice.

Authors:  Brooke M Ahern; Bryana M Levitan; Sudhakar Veeranki; Mihir Shah; Nemat Ali; Andrea Sebastian; Wen Su; Ming C Gong; Jiayang Li; Julian E Stelzer; Douglas A Andres; Jonathan Satin
Journal:  J Biol Chem       Date:  2019-05-30       Impact factor: 5.157

Review 8.  Nitroxyl (HNO) for treatment of acute heart failure.

Authors:  Alessia Arcaro; Giuseppe Lembo; Carlo G Tocchetti
Journal:  Curr Heart Fail Rep       Date:  2014-09

9.  Probenecid as a noninjurious positive inotrope in an ischemic heart disease murine model.

Authors:  Sheryl E Koch; Michael Tranter; Nathan Robbins; Kristin Luther; Umesh Singh; Min Jiang; Xiaoping Ren; Trisha Tee; Leah Smith; Priyanka Varma; W Keith Jones; Jack Rubinstein
Journal:  J Cardiovasc Pharmacol Ther       Date:  2012-12-14       Impact factor: 2.457

Review 10.  Na/Ca exchange and contraction of the heart.

Authors:  Michela Ottolia; Natalia Torres; John H B Bridge; Kenneth D Philipson; Joshua I Goldhaber
Journal:  J Mol Cell Cardiol       Date:  2013-06-12       Impact factor: 5.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.